{"id":"W3135186447","doi":"10.1200/jco.2021.39.6_suppl.106","title":"Impact of concomitant prostate cancer therapy on efficacy and safety of relugolix versus leuprolide in men with advanced prostate cancer: Subgroup analysis from the phase III HERO study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Concomitant; Docetaxel; Urology; Clinical endpoint; Prostate; Testosterone (patch); Internal medicine; Cancer; Subgroup analysis; Oncology; Enzalutamide; Gynecology; Randomized controlled trial; Androgen receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005184105,0.001112379,0.003351075,0.0005520168,0.0002331208,0.001014382,0.0007396473,0.0008815939,0.001637511],"category_scores_gemma":[0.003515554,0.0003922782,0.01018895,0.0005636812,0.0004154748,0.0004999919,0.0005091266,0.001182643,0.0001956678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006495354,"about_ca_system_score_gemma":0.0007006043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007561399,"about_ca_topic_score_gemma":0.002702053,"domain_scores_codex":[0.9972464,0.001638631,0.0002982809,0.0003100306,0.0002873838,0.0002193922],"domain_scores_gemma":[0.9977365,0.001018167,0.0005592095,0.0003569257,0.00009187545,0.0002374178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8521802,0.001152347,0.05326542,0.00116962,0.06052284,0.0002279626,0.0001083632,0.001865372,0.006288311,0.000115223,0.001060557,0.02204379],"study_design_scores_gemma":[0.3235852,0.1447925,0.3833713,0.0002946671,0.1264754,0.0009014918,0.000397849,0.008378191,0.005517769,0.001195751,0.004873409,0.0002164754],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865834,0.01005859,0.0005709026,0.0001930568,0.0001058472,0.0004482776,0.001182689,0.00003967194,0.0008175962],"genre_scores_gemma":[0.9964905,0.0009641943,0.00036105,0.0002309063,0.00009642477,0.0002597606,0.001215582,0.00001579447,0.0003657549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005184105,"threshold_uncertainty_score":0.02741647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09848423727485707,"score_gpt":0.5165458415783135,"score_spread":0.4180616043034565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}